Dongsheng M. Liu
Nanchang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Efficacy and safety of tetracycline vs. amoxicillin in furazolidone-based rescue therapy for Helicobacter pylori: a real-world analysis.
Journal: Annals of medicine
Published: February 14, 2025
The crosstalk between efflux pump and resistance gene mutation in Helicobacter pylori.
Journal: Gut microbes
Published: July 25, 2024
Treatment failure is a key factor in the development of Helicobacter pylori resistance.
Journal: Helicobacter
Published: March 01, 2024
Impact of Helicobacter pylori colonization density and depth on gastritis severity.
Journal: Annals of clinical microbiology and antimicrobials
Published: June 14, 2023
Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline.
Journal: Expert review of anti-infective therapy
Published: February 16, 2023
Refractory Helicobacter pylori infection and the gastric microbiota.
Journal: Frontiers in cellular and infection microbiology
Published: June 23, 2022
The Activity of Liposomal Linolenic Acid Against Helicobacter pylori In Vitro and Its Impact on Human Fecal Bacteria.
Journal: Frontiers in cellular and infection microbiology
Published: January 29, 2022
Prevalence of Helicobacter pylori babA, oipA, sabA, and homB genes in isolates from Chinese patients with different gastroduodenal diseases.
Journal: Medical microbiology and immunology
Published: January 30, 2020
Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China.
Journal: Antimicrobial agents and chemotherapy
Published: March 06, 2018
New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese prospective, randomized, multicentre trial.
Journal: The Journal of antimicrobial chemotherapy
Published: October 08, 2017
Last Updated: 09/26/2026